Isoniazid Preventive Therapy Associated Hepatotoxicity among Children Living with HIV: Descriptive Case Series at Mildmay Uganda HIV/AIDS Clinic, Uganda

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Physical Medicine and Rehabilitation

• Publication date

  2015-06-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.4236/IJCM.2015.66050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk Factors for Isoniazid Hepatotoxicity in Children With Latent TB and TB: Difference From Adults

  2015cited by this paper
• Isoniazid-Associated Hepatitis

  2015cited by this paper
• Hepatotoxicity in Children Receiving Isoniazid Therapy for Latent Tuberculosis Infection.

  2014influential reference
• The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individuals [Short communication].

  2013cited by this paper
• Drug-Induced Encephalopathy

  2012cited by this paper
• Risk factors for isoniazid hepatotoxicity in children with latent TB and TB: difference from adults.

  2010cited by this paper
• Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.

  2010influential reference
• Isoniazid-Related Hepatic Failure in Children: A Survey of Liver Transplantation Centers

  2007cited by this paper
• Isoniazid toxicity

  2006influential reference
• Risk factors for antituberculous chemotherapy‐induced hepatotoxicity in Japanese pediatric patients

  2002cited by this paper
• Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.

  1996cited by this paper
• Isoniazid-associated hepatitis in 114 patients.

  1975cited by this paper
• Letter: Isoniazid.

  1974cited by this paper
• Letter: Isoniazid prophylaxis.

  1974cited by this paper
• ISONIAZID-INDUCED ENCEPHALOPATHY.

  1965cited by this paper

• Completion Rates and Hepatotoxicity of Isoniazid Preventive Therapy Among Children Living with HIV/AIDS: Findings and Implications in Northwestern Nigeria

  2022cites this paper
• PROVIDER BARRIERS, ENABLERS, AND INCENTIVES ASSOCIATED WITH THE USE OF ISONIAZID PREVENTIVE THERAPY AMONG HIV-INFECTED INDIVIDUALS IN ETHIOPIA

  2017cites this paper